Magnesium sulfate for severe preeclampsia and eclampsia management at the primary healthcare level in sub-Saharan Africa: a systematic review - Summary - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Utilization of Magnesium Sulfate in Managing Severe Preeclampsia and Eclampsia at Primary Healthcare Facilities in Sub-Saharan Africa: A Systematic Review
To synthesize evidence regarding the administration of magnesium sulfate (MgSO₄) for managing preeclampsia and eclampsia at the primary healthcare level in sub-Saharan Africa.
Approach:
Systematic Review: The review followed PRISMA guidelines, identifying studies from January 2003 to December 2024 that described MgSO₄ use in primary healthcare settings.
Key Findings:
Seven studies met inclusion criteria, primarily from Nigeria.
MgSO₄ was available in most primary healthcare facilities, but its utilization was limited.
Task sharing with community health workers (CHWs) was identified as a promising strategy to enhance MgSO₄ use.
Deficiencies were noted in referral systems and patient monitoring mechanisms.
Continuous training and supervision of CHWs are necessary for effective management of preeclampsia.
Limitations:
Limited number of studies included in the review.
Most studies were conducted in Nigeria, which may not represent the entire sub-Saharan Africa region.
Across 3 studies, higher fertility was associated with greater preference for luxury when it was visible, personally relevant, and potentially noticeable to others.
